GL1X · GenesisL1 explorer

Research workbench

No-heme complex in a bacterial nitric oxide synthase. an FE(III)-no may cause nitrosation.

Analyse No-heme complex in a bacterial nitric oxide synthase. an FE(III)-no may cause… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2FC2
Type
protein
Length
724 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nitric oxide synthase
EC
1.14.13.39
UniProt
O34453
Ligands
HEM, HBI, HAR, NO
Pockets
6 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BNitric oxide synthase (EC 1.14.13.39)protein36244% helix, 14% strandO34453

Ligands and binding sites

  • HEM · Protoporphyrin IX containing Fe · ligand · 2 copies · chains A, B
  • HBI · 7,8-dihydrobiopterin · ligand · 2 copies · chains A, B
  • HAR · N-omega-hydroxy-L-arginine · ligand · 2 copies · chains A, B
  • NO · Nitric oxide · ion · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18170.780.8152HAR, NO, HBI, HEM
27880.780.8155HEM, NO, HAR
3980.370.7518empty
4870.340.7416empty
5650.340.7615empty

Compared structures

  • 2FC2 · NO-HEME complex in a bacterial nitric oxide synthase. An Fe(III)-NO may cause nitrosation. · the same entry in another collection · chain B against B, TM-score 1.00
  • O34453 · AlphaFold monomer V2.0 prediction for nitric oxide synthase oxygenase (O34453) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.